» Articles » PMID: 25171187

Epinephrine Evokes Renalase Secretion Via α-adrenoceptor/NF-κB Pathways in Renal Proximal Tubular Epithelial Cells

Overview
Publisher Karger
Specialty Nephrology
Date 2014 Aug 30
PMID 25171187
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: Renalase is a recently discovered, kidney-specific monoamine oxidase that metabolizes circulating catecholamines. These findings present new insights into hypertension and chronic kidney diseases. Previous data demonstrated that renalase was mainly secreted from proximal tubules which could be evoked by catecholamines. The purpose of this study is to investigate whether renalase expression is induced by epinephrine via α-adrenoceptor/NFκB pathways.

Methods: HK2 cells were utilized to explore renalase expression in response to epinephrine in vitro. Phentolamine, an α-adrenoceptor antagonist, and Tosyl Phenylalanyl Chloromethyl Ketone (TPCK) were used to block α-adrenoceptor and to knock down the transcription factor NFκB, respectively. Renalase expression was analyzed using Western blot and quantitative PCR.

Results: Both protein and mRNA levels of renalase in HK2 cells increased in response to epinephrine (P<0.05). Epinephrine-evoked renalase expression was attenuated by phentolamine and TPCK separately (P<0.05).

Conclusion: Epinephrine evokes renalase secretion via α-adrenoceptor/NF-κB pathways in renal proximal tubular epithelial cells.

Citing Articles

Renalase rs2296545 variant improve hypertension susceptibility by modifying binding affinity to catecholamines in obstructive sleep apnea.

Shen H, Yang J, Xue W, Wei Z, Li L, Guan J Hypertens Res. 2024; 47(11):3200-3213.

PMID: 39232213 PMC: 11534681. DOI: 10.1038/s41440-024-01850-0.


The Multi-Faceted Nature of Renalase for Mitochondrial Dysfunction Improvement in Cardiac Disease.

Stojanovic D, Stojanovic M, Milenkovic J, Velickov A, Ignjatovic A, Milojkovic M Cells. 2023; 12(12).

PMID: 37371077 PMC: 10297141. DOI: 10.3390/cells12121607.


Renalase Challenges the Oxidative Stress and Fibroproliferative Response in COVID-19.

Stojanovic D, Stojanovic M, Milenkovic J, Velickov A, Ignjatovic A, Milojkovic M Oxid Med Cell Longev. 2022; 2022:4032704.

PMID: 36132227 PMC: 9484957. DOI: 10.1155/2022/4032704.


Renalase: a novel regulator of cardiometabolic and renal diseases.

Vijayakumar A, Mahapatra N Hypertens Res. 2022; 45(10):1582-1598.

PMID: 35941358 PMC: 9358379. DOI: 10.1038/s41440-022-00986-1.


The Scientific Rationale for the Introduction of Renalase in the Concept of Cardiac Fibrosis.

Stojanovic D, Mitic V, Stojanovic M, Milenkovic J, Ignjatovic A, Milojkovic M Front Cardiovasc Med. 2022; 9:845878.

PMID: 35711341 PMC: 9193824. DOI: 10.3389/fcvm.2022.845878.